Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1996-03-28
1997-09-23
Criares, Theodore J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514324, 514333, 514422, 514428, 514443, 514578, 514296, A61K 3144, A61K 31445, A61K 3140, A61K 31185
Patent
active
056705140
ABSTRACT:
The present invention provides methods of inhibiting bone loss in mammals via the administration to a mammal in need of such treatment an effective amount of a compound from a series of benzoquinolin-3-ones. Such compounds also are sequentially or concurrently coadministered with a bone antiresorptive agent or a bone anabolic agent.
REFERENCES:
patent: 5239075 (1993-08-01), Audia et al.
Anderson, et al., Proc. Natl. Acad. Sci. USA, 87:3640 (1990).
Anderson, et al., Nature, 354:159-61 (1991).
Matzkin, et al., Clinical Endocrinol., 37:432-436 (1992).
Audia James E.
Neubauer Blake L.
Boone David E.
Criares Theodore J.
Eli Lilly and Company
Sales James J.
LandOfFree
Compositions for inhibiting bone loss does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions for inhibiting bone loss, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions for inhibiting bone loss will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1938760